MACCHIA, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 610
EU - Europa 585
AS - Asia 555
SA - Sud America 172
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.940
Nazione #
US - Stati Uniti d'America 590
SG - Singapore 264
RU - Federazione Russa 150
BR - Brasile 137
IE - Irlanda 101
IT - Italia 98
CN - Cina 88
VN - Vietnam 88
DE - Germania 63
HK - Hong Kong 55
FR - Francia 41
CZ - Repubblica Ceca 34
GB - Regno Unito 18
SE - Svezia 18
AR - Argentina 13
FI - Finlandia 13
UA - Ucraina 10
ID - Indonesia 9
MX - Messico 9
BD - Bangladesh 8
CA - Canada 8
IN - India 8
TR - Turchia 8
BE - Belgio 6
VE - Venezuela 6
ES - Italia 5
RS - Serbia 5
AT - Austria 4
GR - Grecia 4
LT - Lituania 4
NL - Olanda 4
PK - Pakistan 4
CL - Cile 3
CO - Colombia 3
IQ - Iraq 3
IR - Iran 3
KE - Kenya 3
PL - Polonia 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
BO - Bolivia 2
EC - Ecuador 2
JP - Giappone 2
MY - Malesia 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
KZ - Kazakistan 1
LY - Libia 1
MA - Marocco 1
ME - Montenegro 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
SN - Senegal 1
TW - Taiwan 1
Totale 1.940
Città #
San Jose 184
Singapore 107
Dublin 101
Dallas 70
Ashburn 66
Hong Kong 55
Beijing 37
Ho Chi Minh City 36
Munich 36
New York 35
Santa Clara 30
Lauterbourg 29
Chandler 25
Bari 22
The Dalles 19
Moscow 18
Brno 17
Olomouc 17
Hanoi 14
São Paulo 14
Boardman 13
Helsinki 12
Nyköping 12
Frankfurt am Main 10
London 9
Assago 8
Düsseldorf 7
Los Angeles 7
Brussels 6
Curitiba 6
Ann Arbor 5
Brooklyn 5
Council Bluffs 5
Jacksonville 5
Biên Hòa 4
Bologna 4
Can Tho 4
Dhaka 4
Falkenstein 4
Istanbul 4
Manfredonia 4
Mexico City 4
Milan 4
Porto Alegre 4
Rome 4
San Francisco 4
Toronto 4
Belgrade 3
Belo Horizonte 3
Boston 3
Caracas 3
Chicago 3
Da Nang 3
Dearborn 3
Fortaleza 3
Haiphong 3
Kozani 3
Maceió 3
Nairobi 3
Princeton 3
Pune 3
Rio de Janeiro 3
Seattle 3
Tashkent 3
Amsterdam 2
Ankara 2
Asunción 2
Bitonto 2
Campobasso 2
Charlotte 2
Hillsboro 2
Joinville 2
Karachi 2
Kashan 2
Kuala Lumpur 2
La Paz 2
Manaus 2
Mesagne 2
Monmouth Junction 2
Montevideo 2
Montreal 2
Nuremberg 2
Phoenix 2
Redwood City 2
Reggio Emilia 2
Reston 2
Roubaix 2
San Juan Bautista 2
Stockholm 2
Tunis 2
Tuxtla Gutiérrez 2
Uberaba 2
Vĩnh Long 2
Abidjan 1
Afogados da Ingazeira 1
Aktobe 1
Almenno San Salvatore 1
Americana 1
Andover 1
Andradina 1
Totale 1.210
Nome #
FOURIER TRANSFORM ION CYCLOTRON RESONANCE MASS SPECTROMETRY (FT-ICR-MS) FOR HIGH-RESOLUTION ANALYSIS OF FENNEL PROTEINS 152
Adult Renal Stem/Progenitor Cells Can Modulate T Regulatory Cells and Double Negative T Cells 120
Dermanyssus gallinae in città: serve un approccio multiattoriale in cui il veterinario è decisivo 113
When there is no communication between urban planners and public health operators: urban Dermanyssus gallinae infestations in humans 90
Dermanyssosis in the Urban Context: When the One Health Paradigm Is Put into Practice 84
Wasp immunotherapy induced long-term and IgG4-independent protection 79
La disfunzione psicosomatica delle corde vocali 72
Omalizumab nell'orticaria cronica spontanea: uno studio real-life su 14 pazienti 71
Real-world experience with dupilumab in severe asthma: One-year data from an italian named patient program 69
Reazioni ritardate a farmaci: dal test di proliferazione linfocitaria alla desensibilizzazione 67
Studi su Omalizumab nella terapia dell'asma severo. Valutazione degli effetti sulla risposta immunologica IgE in vivo. Valutazione della tollerabilità 65
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 65
Omalizumab in long-term treatment of refractory chronic spontaneus urticaria:effects of discontinuation 62
Duration of chronic spontaneous urticaria remission after omalizumab discontinuation: A long-term observational study 61
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy 61
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 59
A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic Dermatitis 58
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response 57
Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review 57
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 56
Association between γ marker, human leucocyte antigens and killer immunoglobulin-like receptors and the natural course of human cytomegalovirus infection: a pilot study performed in a Sicilian population 56
Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis 55
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 53
Desensitization in Iron Product Allergy 51
Two-year follow-up after drug desensitization in mucopolysaccharidosis 50
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 47
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus 45
Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2‐year real‐life study 45
Immunological and non-immunological mechanisms of allergic diseases in the elderly: Biological and clinical characteristics 43
Use of Dupilumab for 543 Adult Patients with Moderate-To-Severe Atopic Dermatitis: A Multicenter, Retrospective Study 40
The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans 36
Totale 2.039
Categoria #
all - tutte 10.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 2 1 2
2021/202230 1 1 3 1 0 2 0 0 9 6 0 7
2022/2023162 10 9 5 5 12 18 4 14 64 4 9 8
2023/2024230 11 0 43 1 10 87 4 7 3 0 0 64
2024/2025477 21 4 18 10 35 51 40 39 122 29 51 57
2025/20261.100 108 88 181 187 29 55 197 130 70 55 0 0
Totale 2.039